Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Adv Mater. 2019 Jun 6;31(33):e1901071. doi: 10.1002/adma.201901071

Figure 2.

Figure 2.

(A-E) Catheter-based endovascular approaches to the treatment of cancer (A-E and F-G) and benign conditions (H-J and K-N). A) Digital subtraction angiography (DSA) from a catheter inside the celiac artery shows a liver tumor blush in the liver (black arrow). B) The same lesion is demonstrated in a contrast enhanced liver MRI measuring more than 6 cm in diameter. C) Following high dose segmentectomy radioembolization, the lesion is completely ablated allowing the patient to receive potentially curative surgical resection in D) with a 6 month follow-up CT imaging E) showing absence of any malignancy. F) and G) demonstrates MRI images before and after TACE embolization of a 4 cm liver tumor; white arrow in G) shows complete ablation of tumor. H) DSA from the prostate artery in a patient benign prostatic hyperplasia (BPH); corresponding Dyna-CT at the time of procedure is shown in I) Using particulate embolization, this prostate artery was completely blocked in J) (white arrow). (K-N) demonstrates particulate embolization of fibroids in uterus K). DSA of the uterine artery in L) and M) demonstrates the large fibroids; these were successfully embolized and follow-up MRI in N) shows successful treatment of the fibroids.